Cannabinoids improve sleep, but mild side effects remain common
Efficacy of cannabinoids for insomnia and sleep disturbance: A systematic review and meta-analysis of randomized controlled trials.
AI Summary
This systematic review and meta-analysis combined 10 randomized controlled trials involving 2,134 adults with insomnia or poor sleep quality. Compared with placebo or melatonin, cannabinoids significantly reduced insomnia severity and improved overall sleep quality. Participants also slept longer—an average increase of 33.99 minutes—and had a 4.31% improvement in sleep efficiency. Time needed to fall asleep decreased modestly by 12 minutes.
Side effects were more common among people taking cannabinoids, with mild dizziness and dry mouth reported most often. No serious harms were observed in the included trials, but the analysis found that adverse events overall were nearly four times more frequent than with comparison treatments. The findings suggest that cannabinoids may be a potential option for managing insomnia, while larger and longer-term studies are still needed to determine the best doses and whether benefits persist over time.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Sleep research papers you might find interesting.
Language models can extract documented cannabis use, but need validation
UK registry study found early PTSD score improvements, then a plateau
A planned pilot trial will test cannabis gummy feasibility for cancer-related…
Explore More Research
Stay informed about the latest cannabis science.